Biomarker Discovery & Development | Whitepapers & Reports
Gryolab - Selective and Robust Biomarker Quantification
28 February 2023
The use of biomarkers in biotherapeutic development to monitor drug pharmacodynamics, safety, and efficacy has been steadily increasing in an FDA-supported effort to guide decision making and improve the success of new therapeutics in clinical studies.
Related Resources
Related Online Activities
Join the conversation with our upcoming Monthly Science Exchanges and Webinars:Subscribe to our newsletter
Sign up for our monthly Newsletter to keep up with all things Precision Medicine